, Tracking Stock Market Picks
Enter Symbol:
C.r. Bard, Inc. (BCR) [hlAlert]

Hold BCR
up 18.87 %

C.r. Bard, Inc. (BCR) downgraded to Hold by Morgan Joseph

Posted on: Tuesday,  Feb 1, 2011  8:25 AM ET by Morgan Joseph

Morgan Joseph rated Hold C.r. Bard, Inc. (NYSE: BCR) on 02/01/2011. Previously Morgan Joseph rated Buy C.r. Bard, Inc. (NYSE: BCR) on
07/08/2010., when the stock price was $78.87. Since then, C.r. Bard, Inc. has gained 18.88% as of 02/01/2011's recent price of $93.76.
If you would have followed the previous Morgan Joseph's recommendation on BCR, you would have gained 18.87% of your investment in 208 days.

C.R. Bard, Inc. is one of the worldwide leaders in developing, manufacturing, and supplying healthcare products that focus on Vascular, Urology, and Oncology Disease States. In addition, Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair, performance irrigation, hemostasis, and other areas.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/1/2011 8:25 AM Hold
as of 12/30/2011
1 Week   
1 Month   
3 Months   
1 YTD up  2.16 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2010 8:25 AM Buy
78.87 97.00
3/10/2010 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy